Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to help breast cancer patients stay employed

NCT ID NCT03572374

Symptom relief Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a mobile app called TEAMWork that gives breast cancer patients advice on talking to their employers and doctors about work. The goal is to help patients keep their jobs during and after treatment. About 546 adults with breast cancer who are about to start or are currently receiving treatment will try the app and share feedback to improve it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 546 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2019

Expected to finish

Oct 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 64 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patient Usability Testing Inclusion Criteria: * History of a cancer diagnosis * At least 18 years of age * Male or Female * The ability to give informed consent in English or Spanish * Able to use and read a smartphone (iPhone or Android) * Has a smartphone (iPhone or Android) Community Usability Testing Inclusion Criteria: * At least 18 years of age * Male or Female * The ability to give informed consent in English or Spanish * Able to use and read a smartphone (iPhone or Android) * Has a smartphone (iPhone or Android) Focus Group and Interview Inclusion Criteria: * Completed chemotherapy treatment for stage I-III breast cancer. * Age 18 to 64 (inclusive) * Female * Paid employment (full time or part time) in the three months prior to diagnosis or at time of consent to MSK protocol #10-071 (PI: Blinder) * The ability to give informed consent in English or Spanish * Able to use and read a smartphone (iPhone or Android) * Has a smartphone (iPhone or Android) For Cohort 2: * Participants was covered by Emergency Medicaid at the time of diagnosis and/or at any point during their treatment for breast cancer RCT Inclusion Criteria: * Localized invasive breast cancer (not stage 0 or stage IV) per EMR or breast cancer (not stage 0 or stage IV) per self-report for community participants * If electronic medical record does not specify stage and patient is undergoing (neo)adjuvant chemotherapy, assume stage is I, II or III * Planning to undergo or undergoing adjuvant or neoadjuvant chemotherapy per EMR or planning to undergo or undergo chemotherapy per self-report for community participants * Age 18 to 64 (inclusive) * Female * Employment statue of (full time or part time) (those who are on disability leave/medical leave, and other unique employment circumstances at the PI's dicretion are eligible) * Language preference as English or Spanish * Able to use and read a smartphone or tablet (e.g. iPad, iPhone or Android) * Has access to a smartphone or tablet (e.g. iPad, iPhone or Android) Exclusion Criteria: RCT Exclusion Criteria: * Stage 0 breast cancer (DCIS only) * Stage IV (metastatic) breast cancer * Recurrence with metastases of breast cancer * Participants or family members who are participating in MSK IHCD studies related to social determinants of health

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bellevue Hospital Center (Data Collection Only)

    NOT_YET_RECRUITING

    New York, New York, 10016, United States

  • Lincoln Medical and Mental Health Center

    ACTIVE_NOT_RECRUITING

    The Bronx, New York, 10451, United States

  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-up)

    RECRUITING

    Basking Ridge, New Jersey, 07920, United States

  • Memorial Sloan Kettering Bergen (Consent and Follow up)

    RECRUITING

    Montvale, New Jersey, 07645, United States

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Monmouth (Consent and Follow-up)

    RECRUITING

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Westchester (Consent and Follow-up)

    RECRUITING

    Harrison, New York, 10604, United States

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10467, United States

  • Queens Cancer Center of Queens Hospital

    RECRUITING

    Jamaica, New York, 11432, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.